Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Autologous CD34+ cells transduced with a lentiviral vector containing the human Wiskott-Aldrich syndrome gene

EU orphan designation number: EU/3/13/1196   
Active ingredient: Autologous CD34+ cells transduced with a lentiviral vector containing the human Wiskott-Aldrich syndrome gene
Indication: Treatment of Wiskott-Aldrich-syndrome
Sponsor: Généthon
1 bis rue de l’internationale, F-91000 Evry, France

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
14/10/2013 Centralised Orphan - Designation EMA/OD/104/13 (2013)6741 of 07/10/2013